chelators.
The acquisition of iron is essential for survival, growth, and virulence of bacterial pathogens. Pathogenic bacteria acquire iron through iron--siderophore and heme protein scavenging systems. Vibrio cholerae, a Gram--negative bacteria, is the causative agent of cholera 1, 2 . The genome sequence of V.
cholerae and bioinformatics--based analyses predict the presence of putative genes encoding proteins termed Hut (Heme utilization) for heme acquisition 3, 4 . We previously found that one of these Hut proteins, HutZ, degrades heme to β-- or δ--biliverdin in vitro
5
. To quantify the iron released from heme by degradation, we added ferrozine, which forms a stable complex with iron, to a reaction solution containing heme--HutZ and ascorbic acid. We serendipitously found that the reaction proceeded very slowly in the presence of ferrozine. This result indicates that iron chelators can inhibit the heme--degradation reaction of HutZ. Thus, in the current study, we investigated the mechanism by which iron chelators inhibit heme degradation.
As shown in Fig. 1 , which presents spectral changes following addition of ascorbic acid to ferric heme--HutZ, ascorbic acid caused a decrease in the Soret band at 406 nm, attributable to heme breakdown (Fig. 1A) , as previously reported 5 . Addition of ferrozine 60 min after the reaction resulted in the appearance of a new band at 562 nm that reflects formation of a ferrozine--iron complex 6 . The heme--degradation ratio, defined as the ratio of iron concentration captured by ferrozine to the initial heme concentration, was 86% (Table S1 †). The most of the remaining absorbance at 406 nm originates from catalase. By contrast, addition of ferrozine prior to the reaction caused little decrease in the Soret band (Fig. 1B) , suggesting that the heme--degradation reaction is repressed by ferrozine (Table S1 †) . This change was not caused by pH change upon addition on ferrozine to the solution and irreversible.
To determine whether inhibition of heme degradation by ferrozine requires the iron--chelating property of ferrozine or a specific interaction of ferrozine with HutZ, we monitored the same reaction in the presence of the typical iron chelators, EDTA, citric acid, and deferoxamine (DFO). Although EDTA did ). Spectra were measured before addition of ascorbic acid and at 8--min intervals for 56 min after the addition of ascorbic acid. Ferrozine (0.10 mM) was added (A) 30 min after the reaction or (B) before the reaction. Dotted line in (A) is the spectrum obtained following addition of ferrozine 60 min after initiation of the reaction.
not affect the heme--degradation reaction, DFO and citric acid, in addition to ferrozine, significantly slowed the reaction (Fig.  S1 †) . The dependence of this inhibition on the concentration of citric acid, ferrozine, and DFO was investigated. Fig. 2 shows the relative intensity ratio of the absorbance at 406 nm at 30 min after the reaction to the initial absorbance, where larger values indicate greater inhibition. The addition of chelators increased this ratio, indicating that the amount of heme degradation was decreased with increasing chelator concentration. The inhibition constant (K i ) for DFO was 5.7 µM, which is smaller than that for ferrozine (52 µM) and citric acid (6.0 × 10 2 µM) (Fig. 2) . The stability constant (K M ) of ferrous iron for DFO (~10 10 M) 7 is higher than that of citric acid (10 4.6 M) 8 , but smaller than that of ferrozine (10 15.6 M) 9 . These results indicate that the inhibition mechanism of iron chelators does not necessarily involve metal chelation.
The deceleration of the enzymatic reaction of HutZ by iron chelators raised the possibility that the chelators affect the structure of the active site of heme--HutZ. To test this, we measured UV--vis absorption and resonance Raman spectra of heme--HutZ. The Soret maximum of ferric heme--HutZ at 406 nm remained after the addition of DFO ( , respectively, measured in the absence of chelators (Fig. S2B †) . We also measured circular dichroism spectra of heme--HutZ to determine whether the addition of DFO caused any secondary structural changes. The ellipticity at 222 nm, which represents the α--helical structure, was virtually insensitive to DFO (Fig. S2C †) , although that below 215 nm was slightly decreased in the presence of DFO. This latter change likely reflects the absorption of DFO itself, which exhibits a broad band between 200 and 240 nm (Fig. S2D †) . These results suggest that DFO does not induce a detectable change in secondary structure. Thus, we postulated that the chelators do not bind to heme--HutZ and disturb its active site. To confirm this, we applied isothermal titration calorimetry to study the energetics of chelator binding to heme--HutZ. Indeed, no binding heat was detected for a solution of DFO and heme--HutZ (Fig. S3 †) , indicating that DFO does not likely bind HutZ directly.
To clarify how chelators cause inhibition, we focused on the heme--degradation mechanism of HutZ, which is a multistep reaction, as shown in Fig. S4 † 5, 10, 11 . Accordingly, we next sought to determine which step is inhibited by the chelators. First, we measured the reduction rate of heme, k 1 , the first step of heme degradation (Fig. S4 †) . Fig. S5 † shows the time course of absorption changes after the addition of ascorbic acid to ferric heme--HutZ, in the presence of CO to prevent oxidation to ferric heme. Upon reduction, the Soret maximum at 406 nm underwent a red shift to 418 nm-the same position of the Soret band in CO--bound heme 5 . The time course of absorbance changes at 418 nm in the absence of DFO was fit to a single exponential, which yielded a k 1 of 0.052 ± 0.005 min --1 . In the presence of DFO, the k 1 was 0.045 ± 0.008 min --1 , showing that DFO does not affect this step. The second step in heme degradation is O 2 binding to ferrous heme (Fig. S4 †) . It is difficult to obtain the rate constant for this step (k 2 ), because O 2 --bound heme--HutZ is rapidly autoxidized to ferric heme 5 , or converted to hydroperoxy heme, leading to degradation of heme. Therefore, we measured the cyanide (CN) ion--binding rate (k 2 ') instead of k 2 . A typical time course for the reaction of heme--HutZ with CN using a stopped--flow apparatus is shown in Fig. S6A †. Under conditions of excess of CN, a pseudo--first rate constant (k obs ) was obtained from the single--exponential fit. The obtained k obs values increased linearly with increasing concentrations of CN (Fig.  S6B †) . The second--order rate constant, k 2 in the presence of DFO. Therefore, the step involving ligand binding to heme is unlikely to be inhibited by DFO. Finally, the rate constant for the formation of verdoheme, k 4 (Fig. S4 †) , was compared. In the reaction with H 2 O 2 , the Soret band disappeared with a concomitant increase in a band at 644 nm 5 ( Fig. S7 †) . The value of k 4 obtained by fitting the data at 644 nm to a single exponential curve, was 0.38 s --1 , which is approximately equal to that in the presence of DFO (0.39 s --1 ). As described above, the rates for heme reduction (k 1 ), ligand binding (k 2 ), and verdoheme formation (k 4 ) were unaffected by the addition of iron chelators. The remaining step is conversion of oxyheme to hydroperoxy heme, with a rate constant of k 3 (Fig.  S4 †) . However, it is difficult to directly measure k 3 owing to the extremely short lifetime of hydroperoxy heme. This step is divided into two steps: the one--electron reduction of oxyheme to Fe(III)--OO -, and protonation of Fe(III)--OO -to hydroperoxy heme. Considering that the addition of DFO does not change k 1 , it would also not alter the redox potential of heme--HutZ, indicating that the rate of one--electron reduction of oxyheme would not be affected. Thus, we postulated that DFO inhibits the second step: protonation of Fe(III)--OO -.
In mammalian heme oxygenase (HO), X--ray crystal structure and other biochemical and biophysical studies suggest that protonation of oxyheme is mediated by distal water molecules, which serve as proton sources (Fig.  S8 †) [11] [12] [13] . , as observed in HO [14] [15] [16] . This isotope effect on heme--degradation by HutZ suggests that a proton source is required for protonation of the Fe(III)--OO -species. In HO--1, the terminal oxygen atom of the heme--bound O 2 interacts with a water molecule, which is stabilized by Asp140 (Fig.  S8 †) 17, 18 . Replacement of Asp140 with alanine substantially suppresses proton transfer to Fe(III)--OO -in HO--1 because of displacement and/or fluctuations of the water molecules [19] [20] [21] . The distal Asp140 allows water molecules in the distal pocket to interact with heme--bound O 2 20, 22 . Although the heme complex of HutZ has not been crystallized, the crystal structure of a homologous protein, HugZ, from Helicobacter pylori suggests that Thr27 of HutZ is present in the active site (Fig. S10 †) 
23
. Thus, we predicted that Thr27 plays a role in protonation of Fe(III)--OO -analogous to that of Asp140 in HO--1. To investigate whether the hydroxyl group at position 27 is essential for protonation of the iron--bound O 2 , we replaced Thr27 with valine or serine, and examined the heme--degradation activity of the resulting mutants. The time course of the decrease in the Soret band revealed that the heme--degradation rate was significantly slower for the heme--HutZ T27V mutant than for heme--HutZ wild--type (WT) (Fig.  3) . In addition, mutation of Thr27 to valine caused a 2--fold decrease in the amount of liberated ferrous iron (Table S1 †) . To investigate the step inhibited in the T27V mutant, we measured the rate constants for heme--degradation (Fig.  S4 †) . The values for k 1 , k 2 , and k 4 for the heme--HutZ T27V mutant were almost the same as those for heme--HutZ WT (Table S2 †) . In contrast, for the T27S mutant, in which the hydroxyl group at position 27 is retained, the heme--degradation rate and amount of iron released from heme were almost identical to those of heme--HutZ WT (Fig. 3 , Table S1 †). These results suggest that the OH group of Thr27 is involved in protonation
These observations indicate that iron chelation perturbs proton transfer from water molecules to Fe(III)--OO -, and Thr27 contributes to the presence of water molecules in the active site. A proposed mechanism for inhibition by iron chelators is illustrated in Fig. 4 . According to this model, iron chelators inhibit the heme--degradation reaction by perturbing localization of the proton source-water molecules-making it difficult for HutZ to form the Fe(III)--OOH species. The exothermic heat of interaction of DFO with distal water molecules would be canceled by the endothermic heat of disruption of the interaction with bulk water molecules (Fig.  S3 †) .
Inhibition of HutZ by iron chelators prompted us to investigate the possibility of antibiotics as inhibitor of HutZ, because tetracycline, which is the most effect current treatments for cholera, is an inhibitor of protein synthesis as well as an iron chelator 24 . Thus, we speculated that 
